Hepatitis C among people who use drugs – Side Event at the Commission on Narcotic Drugs

12 Mar 2018 Bridie Taylor

The prevalence of hepatitis C among people who use drugs remains extremely high. However, the remarkable progress in science and medicine along with a significant scaling up of prevention and harm reduction strategies could make a significant impact on this epidemic.

To address this, the World Hepatitis Alliance is co-sponsoring a side event at the Commission on Narcotic Drugs with Fédération Addiction, International Doctors for Healthier Drug Policies (IDHDP), International Network for People who Use Drugs (INPUD), Médecins du Monde (MdM) and the Norwegian Ministry of Health and Care Services.

This side event will provide an overview of hepatitis among people who use drugs worldwide, and offer insights into some of the most effective interventions for scaling up testing and treatment as well as improving prevention, with presentations from civil society, people who use drugs and government officials.

“Hepatitis C among people who use drugs – the global state and recommendations”

09.00-09.50, Friday, 16 March 2018

Conference Room M5, Vienna International Centre

For more information, please view the event flyer or email us at contact@worldhepatitisalliance.org.

Not attending the Commission on Narcotic Drugs?

Follow the hashtags #CND2018 or #CND61 for updates from the event. Ahead of the CND, the International Drug Policy Consortium developed a webinar explaining the Commission’s functioning, key issues for 2018 and guidance to facilitate NGO engagement. Watch it here.